CDC Vaccine Basics.......

Vaccines

Monitoring health problems after vaccination is essential to ensure vaccines are held to the highest standard of safety. Years of testing are required by law before a vaccine can be licensed. Once licensed and in use, vaccines are continuously monitored for safety and efficacy.

Vaccines

• Diphtheria, Tetanus, and Acellular Pertussis (DTaP)
• Haemophilus Influenzae Type B (Hib)
• Human Papillomavirus (HPV)
• Measles, Mumps, Rubella (MMR)
• Measles, Mumps, Rubella, Varicella (MMRV)
• Rotavirus Vaccine

Frequently Asked Questions (FAQs)

• Guillain-Barré Syndrome (GBS) and Menactra® Meningococcal Vaccine
• Hepatitis B (Hep B) Vaccine and Multiple Sclerosis (MS)
• HPV Vaccine Safety
• Multiple Vaccines and the Immune System
• Safety of the 2009 H1N1 Influenza Vaccine
• Syncope (Fainting) After Vaccination
• Thimerosal (Ethylmercury)
• Vaccine Adjuvants
• Vaccine Recalls
• Vaccine Safety

Scientific Articles

Davis RL, Kolczak M, Lewis E, Nordin J, Goodman M, Shay DK, Platt R, Black S, Shinefield H, Chen RT. Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology 2005;16(3): 336–341.
Chen RT, DeStefano F, Davis RL, Jackson LA, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Ward JI, Marcy SM. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA.  [PDF--312.49 KB] Bulletin of the World Health Organization 2000;78(2):186–194.
Iskander J, Pool V, Zhou W, English-Bullard R; The VAERS Team. Data mining in the US using the Vaccine Adverse Event Reporting System. Drug Safety 2006;29(5):375–384.
Lieu TA, Black SB, Ray P, Chellino M, Shinefield HR, Adler NE. Risk factors for delayed immunization among children in an HMO. American Journal of Public Health 1994;84(10):1621–1625.
Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, Chen RT. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatric Infectious Disease Journal 2004;23(4):287-294.